From DCAT Value Chain Insights (VCI)
Donald E. Morel, Jr, PhD, chairman of the board and chief executive officer of West Pharmaceutical Services Inc., has announced his intention to retire at the company's annual meeting in May 2015. The West board of directors has retained Russell Reynolds Associates, an executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
Source: West Pharmaceutical Services Inc.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription